3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Unknown
4
Recruiting
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
313
Lymphoma
309
Lymphoma, Non-Hodgkin
227
Lymphoma, Large B-Cell, Diffuse
223
Lymphoma, Follicular
203
Leukemia, Lymphocytic, Chronic, B-Cell
168
Lymphoma, B-Cell
150
Recurrence
130
Burkitt Lymphoma
120
Lymphoma, Mantle-Cell
115
Leukemia, Myeloid, Acute
106
Hodgkin Disease
102
Leukemia
101
Multiple Myeloma
95
Lymphoma, B-Cell, Marginal Zone
88
Neoplasms
81
Myelodysplastic Syndromes
69
Lymphoma, T-Cell, Peripheral
64
Hematologic Neoplasms
61
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
58
Lymphoma, T-Cell
51
Lymphoma, T-Cell, Cutaneous
44
Waldenstrom Macroglobulinemia
42
Leukemia, Biphenotypic, Acute
35
Mycosis Fungoides
32
Lymphoproliferative Disorders
30
Leukemia, B-Cell
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Breast Neoplasms
28
Myeloproliferative Disorders
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Intellectual Disability
×
Lymphoid
×
Clear all
NCT06691698
2025-08-29
CO-OPIF
Örebro University, Sweden
Phase NA
Recruiting
60 enrolled